Article

A Case of COVID-19 Successfully Treated with Minocycline and Saiko-Keishi-To

2022-12-27

Abstract excerpt

Since the beginning of 2020, tetracycline (TC), such as minocycline (MINO), has been used to inhibit coronavirus disease 2019 (COVID-19). Traditional Japanese Kampo medicine, such as Saiko-keishi-to (SKT), has recently received a lot of attention for its anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) effects. We describe a COVID-19 patient treated with MINO and SKT in anticipation of their anti-...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: ee88ad89-d865-5195-8817-b104d06137f1
DOI: 10.20944/preprints202212.0502.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 8 closest

A Case of COVID-19 Successfully Treated with Minocycline and Saiko-Keishi-ToDOI 10.20944/preprints202212.0502.v1Read

Why does Japan have so few cases of COVID-19?Semantic proximity Read

Molecular mechanisms of 10-Butyl Ether Minocycline (BEM), a novel non-antibiotic tetracycline, as a potential treatment for inflammatory and neuroimmune-related disordersSemantic proximity Read

Doxycycline: An essential tool for Alzheimer’s diseaseSemantic proximity Read

Minocycline inhibits cell death and decreases mutant Huntingtin aggregation by targeting Apaf-1.Semantic proximity Read

Minocycline for Huntington’s disease: An open label studySemantic proximity Read

Can minocycline prevent the onset of Alzheimer's disease?Semantic proximity Read

Molecular Mechanisms of the Medicines for COVID-19Semantic proximity Read

COVID-19 and COVID-19 Vaccine in Japan—A Review from a General Physician's PerspectiveSemantic proximity Read